https://www.gosh.nhs.uk/news/deconstruction-of-the-frontage-building-starting/

Deconstruction of the Frontage Building starting

14 Feb 2025, 9 a.m.

A photograph showing scaffolding and sheeting around the frontage building

We are pleased to announce that deconstruction of the Frontage Building will start on Monday 17 February.

This is a major step forward and means we are nearer to realising our ambition to provide a new home for cancer services, as well as more space for our school, imaging, critical care and theatre services and an amazing new entrance for the whole hospital.

The deconstruction process will be managed carefully by our contractor Sisk and the works will be overseen by the GOSH CCC team.

Information for visitors to GOSH

While it is exciting that we are developing this amazing new facility, we know that this activity may make things feel different for visitors to the hospital.

From your ward window you may be able to see the deconstruction site and works on site. There may be noise at times, but please note there are quiet periods during the day when the sound limits are lower.

These times are:

  • 7am - 8am
  • 12pm - 1pm
  • 5pm - 6pm.

There are maximum limits at all times and no work takes place after 6pm Monday-Friday, or after 1pm on Saturdays.

Please talk to your ward team if the work is disturbing you or you have any concerns.

Thank you for bearing with us as we develop the new building. Contact us if you have any questions or concerns:
Email: ccc@gosh.nhs.uk

Find out more about the Children's Cancer Centre, including how we are managing the deconstruction process.

Study linking data from 85% of children in England compares rare cardiac risks post-COVID vs vaccination

Our new strategy has launched: Together We Power Care

We’re proud to share our new Trust Strategy for Great Ormond Street Hospital for Children, TOGETHER WE POWER CARE. This is our vision for the future, and the steps we’ll take to achieve our ambitions of delivering life-changing care for our children.

GOSH contributes to landmark UAE-UK paper on AI in healthcare

We're proud to have contributed to a new paper published by the UAE-UK Business Council, exploring future opportunities for collaboration in artificial intelligence (AI) in healthcare between the United Kingdom and the United Arab Emirates.

Landmark gene therapy study shows safety for children

Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.